Search

everythinglearnresearchcommunity

for

Search:↓

The new microneedle system effectively delivers minoxidil for hair regrowth with minimal side effects.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Microneedling improves skin and hair conditions by enhancing treatment absorption and stimulating growth factors.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Antibody treatments show promise for hair loss but need more research.

Hair follicles could be used to deliver drugs effectively, with the right understanding and methods.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Certain skin drugs and topical agents, including some natural extracts and fragrances, can cause allergic reactions. Some hair dyes and extensions, as well as minoxidil, a hair growth treatment, can also cause allergies. Botulinum toxin A can effectively reduce sweat but may have temporary side effects.

Injecting newborn mice with a niacin blocker caused skin, gut, and brain damage similar to human pellagra.

Nanocarriers can improve skin treatments by effectively delivering drugs and enhancing skin hydration.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

Non-drug methods effectively managed agitation in a patient with a heart device, leading to improved mental function.

Detachable microneedles with chitin derivatives effectively promote hair regrowth in androgenic alopecia without toxicity.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Adults with atopic dermatitis showed similar adherence to different forms of hydrocortisone cream, but actual use varied despite self-reports of near-perfect usage.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

Botulinum toxin injections can reduce hair loss and stimulate new hair growth in some men with male pattern baldness.

Hair follicles could be used for targeted drug delivery, with liposomal systems showing promise for this method.

Hydrogel microneedles with special nanoparticles and growth factor improve hair growth better than minoxidil for hair loss treatment.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Diabetic wounds heal slower than healthy wounds.